CA1065307A - PROCEDE DE PURIFICATION DE LA .beta.1-GLYCOPROTEINE SPECIFIQUE AUX FEMMES ENCEINTES - Google Patents
PROCEDE DE PURIFICATION DE LA .beta.1-GLYCOPROTEINE SPECIFIQUE AUX FEMMES ENCEINTESInfo
- Publication number
- CA1065307A CA1065307A CA250,439A CA250439A CA1065307A CA 1065307 A CA1065307 A CA 1065307A CA 250439 A CA250439 A CA 250439A CA 1065307 A CA1065307 A CA 1065307A
- Authority
- CA
- Canada
- Prior art keywords
- pregnancy
- specific
- glycoprotein
- beta
- purification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims abstract description 14
- 230000008569 process Effects 0.000 title claims abstract description 13
- 238000000746 purification Methods 0.000 title claims abstract description 5
- 230000035935 pregnancy Effects 0.000 claims abstract description 14
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims abstract description 7
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims abstract description 7
- CGMRCMMOCQYHAD-UHFFFAOYSA-J dicalcium hydroxide phosphate Chemical compound [OH-].[Ca++].[Ca++].[O-]P([O-])([O-])=O CGMRCMMOCQYHAD-UHFFFAOYSA-J 0.000 claims abstract 2
- 229910019142 PO4 Inorganic materials 0.000 claims description 6
- 235000021317 phosphate Nutrition 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 5
- 239000010452 phosphate Substances 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 229910000160 potassium phosphate Inorganic materials 0.000 claims 1
- 235000011009 potassium phosphates Nutrition 0.000 claims 1
- 239000001488 sodium phosphate Substances 0.000 claims 1
- 229910000162 sodium phosphate Inorganic materials 0.000 claims 1
- 101710084021 Large envelope protein Proteins 0.000 description 5
- 239000012535 impurity Substances 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000037189 immune system physiology Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Reproductive Health (AREA)
- Analytical Chemistry (AREA)
- Pregnancy & Childbirth (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Gynecology & Obstetrics (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/569,476 US4065445A (en) | 1971-09-29 | 1975-04-18 | Pregnancy-specific β1 -glycoprotein and process for isolating it |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1065307A true CA1065307A (fr) | 1979-10-30 |
Family
ID=24275609
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA250,426A Expired CA1065305A (fr) | 1975-04-18 | 1976-04-15 | PROCEDE D'ENRICHISSEMENT DE LA .beta.1-GLYCOPROTEINE SPECIFIQUE AUX FEMMES ENCEINTES |
| CA250,439A Expired CA1065307A (fr) | 1975-04-18 | 1976-04-15 | PROCEDE DE PURIFICATION DE LA .beta.1-GLYCOPROTEINE SPECIFIQUE AUX FEMMES ENCEINTES |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA250,426A Expired CA1065305A (fr) | 1975-04-18 | 1976-04-15 | PROCEDE D'ENRICHISSEMENT DE LA .beta.1-GLYCOPROTEINE SPECIFIQUE AUX FEMMES ENCEINTES |
Country Status (18)
| Country | Link |
|---|---|
| JP (2) | JPS51133406A (fr) |
| AT (2) | AT344734B (fr) |
| AU (2) | AU503288B2 (fr) |
| BE (2) | BE840913A (fr) |
| CA (2) | CA1065305A (fr) |
| DE (1) | DE2612479A1 (fr) |
| DK (2) | DK173576A (fr) |
| ES (2) | ES446939A1 (fr) |
| FI (2) | FI56184C (fr) |
| FR (2) | FR2307815A1 (fr) |
| GB (2) | GB1541453A (fr) |
| IE (2) | IE42679B1 (fr) |
| IT (1) | IT1060215B (fr) |
| LU (2) | LU74782A1 (fr) |
| NL (2) | NL7603902A (fr) |
| NO (2) | NO145405C (fr) |
| NZ (1) | NZ180619A (fr) |
| SE (2) | SE7604483L (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2720704C2 (de) * | 1977-05-07 | 1986-09-25 | Behringwerke Ag, 3550 Marburg | Neues Glycoprotein, Verfahren zu seiner Herstellung und seine Verwendung |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5325030B2 (fr) * | 1972-12-19 | 1978-07-24 |
-
1976
- 1976-03-24 DE DE19762612479 patent/DE2612479A1/de active Pending
- 1976-04-12 ES ES446939A patent/ES446939A1/es not_active Expired
- 1976-04-12 ES ES446944A patent/ES446944A1/es not_active Expired
- 1976-04-13 NL NL7603902A patent/NL7603902A/xx not_active Application Discontinuation
- 1976-04-13 NL NL7603903A patent/NL7603903A/xx not_active Application Discontinuation
- 1976-04-14 FI FI761017A patent/FI56184C/fi not_active IP Right Cessation
- 1976-04-14 DK DK173576A patent/DK173576A/da active IP Right Grant
- 1976-04-14 NO NO761305A patent/NO145405C/no unknown
- 1976-04-14 NO NO761306A patent/NO761306L/no unknown
- 1976-04-14 DK DK173876A patent/DK173876A/da active IP Right Grant
- 1976-04-14 FI FI761016A patent/FI54486C/fi not_active IP Right Cessation
- 1976-04-15 SE SE7604483A patent/SE7604483L/ not_active Application Discontinuation
- 1976-04-15 GB GB15557/76A patent/GB1541453A/en not_active Expired
- 1976-04-15 NZ NZ180619A patent/NZ180619A/xx unknown
- 1976-04-15 AU AU13081/76A patent/AU503288B2/en not_active Expired
- 1976-04-15 SE SE7604484A patent/SE419340B/xx unknown
- 1976-04-15 CA CA250,426A patent/CA1065305A/fr not_active Expired
- 1976-04-15 IE IE818/76A patent/IE42679B1/en unknown
- 1976-04-15 AU AU13082/76A patent/AU503342B2/en not_active Expired
- 1976-04-15 CA CA250,439A patent/CA1065307A/fr not_active Expired
- 1976-04-15 IE IE817/76A patent/IE42566B1/en unknown
- 1976-04-15 GB GB15558/76A patent/GB1541454A/en not_active Expired
- 1976-04-16 FR FR7611367A patent/FR2307815A1/fr active Granted
- 1976-04-16 IT IT22445/76A patent/IT1060215B/it active
- 1976-04-16 FR FR7611372A patent/FR2307816A1/fr active Granted
- 1976-04-16 AT AT284276A patent/AT344734B/de not_active IP Right Cessation
- 1976-04-16 LU LU74782A patent/LU74782A1/xx unknown
- 1976-04-16 AT AT284176A patent/AT344920B/de not_active IP Right Cessation
- 1976-04-16 LU LU74783A patent/LU74783A1/xx unknown
- 1976-04-17 JP JP51044152A patent/JPS51133406A/ja active Granted
- 1976-04-17 JP JP51044151A patent/JPS51133408A/ja active Pending
- 1976-04-20 BE BE166291A patent/BE840913A/fr not_active IP Right Cessation
- 1976-04-20 BE BE166290A patent/BE840912A/fr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pfeuffer et al. | Adenylate cyclase from bovine brain cortex: purification and characterization of the catalytic unit. | |
| US4217339A (en) | Glycoprotein and process for isolating it | |
| US4191533A (en) | Pregnancy-specific β1 -glycoprotein and process for isolating it | |
| US4041021A (en) | AP-glycoproteins and process for isolating them | |
| CA1110617A (fr) | Glycoproteine et procede d'isolation | |
| US3943245A (en) | Purification of plasminogen | |
| EP0097057B1 (fr) | Méthode de préparation du facteur de croissance épidermique humain | |
| US4348316A (en) | New protein PP15, a process for its preparation and its use | |
| US4468345A (en) | Protein (PP17), a process for concentrating and isolating it and its use | |
| US4065445A (en) | Pregnancy-specific β1 -glycoprotein and process for isolating it | |
| CA1247090A (fr) | Proteine tissulaire pp in18 xx, procede de production et application | |
| Zittle et al. | Use of butanol in the purification of the alkaline phosphatase of bovine milk | |
| Andersson et al. | The effects of organic solvents and temperature on the desorption of yeast 3-phosphoglycerate kinase from immunoadsorbent | |
| CA1065307A (fr) | PROCEDE DE PURIFICATION DE LA .beta.1-GLYCOPROTEINE SPECIFIQUE AUX FEMMES ENCEINTES | |
| CA1101847A (fr) | Traduction non-disponible | |
| US2808362A (en) | Preparation of hyaluronidase | |
| US4325866A (en) | Protein, PP11, a process for its preparation and its use | |
| US4018885A (en) | Steroid-binding globulin and process for preparing it and antibodies thereto | |
| US3763137A (en) | Isolation of orgotein from red blood cells | |
| INOUE et al. | Studies on Phosphoproteins from Fish Eggs I. Isolation and Characterization of a Phosphoprotein from the Eggs of Pacific Herring | |
| JPS6034916A (ja) | 第１ｘ因子および他のビタミンｋ依存性タンパク質の高純度精製 | |
| US3905870A (en) | Purification of kallikrein | |
| US3959249A (en) | Method for isolating transferrines from biological materials | |
| US3591678A (en) | Method of purifying intrinsic factor | |
| US4027012A (en) | Process for the extraction of components having anticoagulant activity "in vivo" from snake venoms and products obtained |